On the segmental front, revenue from Healthcare Services was Rs 2,276.55 crore (up 4.9% YoY), revenue from Pharmacy Distribution was Rs 1,168.31 crore (up 0.1% YoY), revenue from Clinics was Rs 318.28 crore (down 16.5% YoY) in the quarter ended 30 September 2022. Profit before tax in Q2 FY23 stood at Rs 327.07 crore, down by 14.6% from Rs 382.98 crore in Q2 FY22. As on 30 September 2022, Apollo Hospitals had 7,872 operating beds across the network (excluding AHLL & managed beds), out of which 2,423 were new with 1,543 occupied beds. The overall occupancy for hospitals was at 68% versus 60% in the trailing quarter, aided by a robust increase in patient flows across hospitals. Average revenue per operating bed (ARPOB ) (excluding vaccination) stood at Rs 51,136 in H1 FY23 rising 15.7% from Rs 44,186 registered in Q2 FY22. Apollo Hospitals Enterprise is a private sector healthcare provider. It owns and operates hospitals across the country. The scrip rose 4.96% to currently trade at Rs 4,494.70 on the BSE. Powered by Capital Market – Live News
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.